Evidence map›Paper›PMID 37223265›Full record

ArticlePatterns (New York, N.Y.)2023

Application of particle swarm optimization to understand the mechanism of action of allosteric inhibitors of the enzyme HSD17β13.

Amy Ford, Frauke Breitgoff, Miriam Pasquini, Amanda MacKenzie, Stuart McElroy, Steve Baker, Patrizia Abrusci, Simon Varzandeh, Louise Bird, Angeline Gavard and 2 more

Abstract read
In one paragraph

Article in Patterns (New York, N.Y.), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Amy FordExscientia, The Schrödinger Building, Oxford Science Park, Oxford OX4 4GE, UK.
Frauke BreitgoffExscientia, The Schrödinger Building, Oxford Science Park, Oxford OX4 4GE, UK.
Miriam PasquiniExscientia, The Schrödinger Building, Oxford Science Park, Oxford OX4 4GE, UK.
Amanda MacKenzieBioascent, Bo'Ness Road, Chapelhall, Motherwell ML1 5SH, UK.
Stuart McElroyBioascent, Bo'Ness Road, Chapelhall, Motherwell ML1 5SH, UK.
Steve BakerExscientia, The Schrödinger Building, Oxford Science Park, Oxford OX4 4GE, UK.
Patrizia AbrusciExscientia, The Schrödinger Building, Oxford Science Park, Oxford OX4 4GE, UK.
Simon VarzandehExscientia, The Schrödinger Building, Oxford Science Park, Oxford OX4 4GE, UK.
Louise BirdExscientia, The Schrödinger Building, Oxford Science Park, Oxford OX4 4GE, UK.
Angeline GavardExscientia, The Schrödinger Building, Oxford Science Park, Oxford OX4 4GE, UK.
David DamerellExscientia, The Schrödinger Building, Oxford Science Park, Oxford OX4 4GE, UK.
Martin RedheadExscientia, The Schrödinger Building, Oxford Science Park, Oxford OX4 4GE, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Understanding a drug candidate's mechanism of action is crucial for its further development. However, kinetic schemes are often complex and multi-parametric, especially for proteins in oligomerization equilibria. Here, we demonstrate the use of particle swarm optimization (PSO) as a method to select between different sets of parameters that are too far apart in the parameter space to be found by conventional approaches. PSO is based upon the swarming of birds: each bird in the flock assesses multiple landing spots while at the same time sharing that information with its neighbors. We applied this approach to the kinetics of HSD17β13 enzyme inhibitors, which displayed unusually large thermal shifts. Thermal shift data for HSD17β13 indicated that the inhibitor shifted the oligomerization equilibrium toward the dimeric state. Validation of the PSO approach was provided by experimental mass photometry data. These results encourage further exploration of multi-parameter optimization algorithms as tools in drug discovery.

Indexed as

fluorescence thermal shift assayFTSAglobal analysismulti-parameter optimizationparticle swarm optimizationPSO

Identifiers

PMID37223265
PMCPMC10201303

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.